Skip to content

Clinical trials

Observational Fabry Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Phase: Observational Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20021
20031
20051
20071
20091
20104
20121
20131
20142
20161
20181
20202
20212
20221
20234
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting7
Unknown status6
Terminated2
Enrolling by invitation1
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)6
Amicus Therapeutics4
Chiesi Farmaceutici S.p.A.3
O & O Alpan LLC3
Baylor Research Institute2
Lysosomal and Rare Disorders Research and Treatment Center, Inc.2
University of Alabama at Birmingham2
Albert Einstein College of Medicine1
Boston Children's Hospital1
Cedars-Sinai Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease34
Gaucher Disease4
Glycogen Storage Disease Type II3
Lysosomal Storage Diseases3
Niemann-Pick Diseases3
Proteinuria3
Stroke3
Angiokeratoma2
Kidney Failure, Chronic2
Rare Diseases2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.